PK

Perry Karsen

Biotechnology Executive and Board Member

San Francisco Bay Area

Invests in

Stages:

Sectors:

Health & Hospital Services

San Francisco Bay Area

Locations:

San Francisco Bay Area

San Francisco, California

Palo Alto, California

Min Investment:
$10,000,000.00
Max Investment:
$100,000,000.00
Target Investment:
$25,000,000.00

Education

Master of Liberal Arts
Stanford University
(2021 - 2026)
Fellow, Distinguished Careers Institute
Stanford University
(2019 - 2020)
Master of Management
Northwestern University - Kellogg School of Management
(1985 - 1988)
Master of Arts in Teaching Biology
Duke University
(1978 - 1979)
Bachelor of Science in Biology
University of Illinois Urbana-Champaign
(1973 - 1977)

Investments

Agios Pharmaceuticals

Total Funding: $120M

Work Experience

Nitrase Therapeutics

2020

Chair Of The Board Of Directors
2020

2020 - 2024

Chair Of The Board Of Directors
2020 - 2024
Board Member
2020 - 2020

Jounce Therapeutics, Inc.

2016 - 2023

Board Member
2022 - 2023
Chair Of The Board Of Directors
2016 - 2022

Samsara BioCapital

2020 - 2022

Senior Advisor
2020 - 2022

2018 - 2022

Board Member
2018 - 2022

Intellia Therapeutics, Inc.

2016 - 2020

Board Member
2020 - 2020
Chair Of The Board Of Directors
2016 - 2020

Voyager Therapeutics, Inc.

2015 - 2019

Board Of Directors
2015 - 2019

OncoMed Pharmaceuticals

2016 - 2019

Executive Chair Of The Board Of Directors
2016 - 2019

Third Rock Ventures

2016 - 2018

Venture Partner
2016 - 2018

Pliant Therapeutics

2016 - 2017

Chair of the Board of Directors
2016 - 2017